David Krempa - Chief Business Officer at Eton Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Business Officer
Issuer Symbol
ETON on Nasdaq
All Insider Reports
All Insider Reports

David Krempa - trading volume in the past year for Eton Pharmaceuticals, Inc.

Holdings reported by David Krempa for Eton Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 630,238 $9,844,317 $15.62 14 Jan 2026 Direct
Restricted Stock Units 696,749 $206,527 $7.98 12 Jan 2026 Direct Common Stock
Employee Stock Option (Right to Buy) 670,893 12 Jan 2026 Direct Common Stock

Transactions reported by David Krempa for Eton Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.